Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma.


PURPOSE To evaluate the treatment outcome in patients with mucosa-associated lymphoid tissue (MALT)/marginal zone (MZ) non-Hodgkin's lymphoma (NHL). MATERIALS AND METHODS Between 1986 and 2000, 66 patients with clinical stage (CS) I-IV MALT/MZ NHL were treated; these comprise the study population. The progression-free survival (PFS) and overall survival… (More)


  • Presentations referencing similar topics